Imunon, Inc. Files S-1/A Amendment
Ticker: IMNN · Form: S-1/A · Filed: May 19, 2025 · CIK: 749647
Sentiment: neutral
Topics: sec-filing, s-1/a, registration
Related Tickers: IMNN
TL;DR
Imunon (IMNN) filed an S-1/A, looks like they're raising capital. Check the details.
AI Summary
Imunon, Inc. filed an S-1/A amendment on May 19, 2025, for its registration statement under the Securities Act of 1933. The company, formerly known as Celsion Corp and Cheung Laboratories Inc, is incorporated in Delaware and headquartered in Lawrenceville, NJ. The filing relates to the registration of securities, though specific details on the number of shares or dollar amounts are not provided in this excerpt.
Why It Matters
This filing indicates Imunon, Inc. is actively pursuing a securities offering, which could lead to new capital for the company's operations or expansion. Investors should review the full filing for details on the offering and associated risks.
Risk Assessment
Risk Level: medium — S-1/A filings are typically related to capital raises, which inherently carry risks for investors depending on the company's stage and the terms of the offering.
Key Numbers
- 333-286403 — SEC File Number (Identifies this specific registration filing)
- 2834 — SIC Code (Indicates the company operates in Pharmaceutical Preparations)
Key Players & Entities
- Imunon, Inc. (company) — Registrant
- Celsion Corp (company) — Former company name
- Cheung Laboratories Inc (company) — Former company name
- Stacy Lindborg (person) — President and Chief Executive Officer
- May 19, 2025 (date) — Filing date
FAQ
What is the purpose of this S-1/A filing?
This S-1/A filing is an amendment to a Form S-1 Registration Statement under the Securities Act of 1933, indicating Imunon, Inc. is registering securities for sale.
When was this amendment filed?
This amendment was filed with the SEC on May 19, 2025.
What are Imunon, Inc.'s former names?
Imunon, Inc. was formerly known as Celsion Corp and prior to that, Cheung Laboratories Inc.
Where is Imunon, Inc. headquartered?
Imunon, Inc.'s principal executive offices are located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648.
Who is the President and CEO of Imunon, Inc.?
Stacy Lindborg is the President and Chief Executive Officer of Imunon, Inc.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on May 19, 2025 by Stacy Lindborg regarding Imunon, Inc. (IMNN).